- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04820764
EFS of the CardioMech MVRS
Early Feasibility Study of the CardioMech Mitral Valve Repair System (MVRS)
Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of the clinical study is to obtain clinical data on the CardioMech Mitral Valve Repair System (MVRS) in patients diagnosed with moderate to severe (≥3+) or severe (≥4+), symptomatic, degenerative mitral regurgitation and who are determined to be at intermediate or high surgical risk for mitral valve repair, as assessed by the site's multidisciplinary heart team.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Thousand Oaks, California, United States, 91360
- Cardiovascular Institute of Los Robles Health System
-
-
Illinois
-
Evanston, Illinois, United States, 60208
- Northwestern University
-
-
Kansas
-
Wichita, Kansas, United States, 67226
- Ascension St. Francis via Christi
-
-
Minnesota
-
Rochester, Minnesota, United States, 55902
- Mayo Clinic
-
Saint Cloud, Minnesota, United States, 56303
- CentraCare Heart & Vascular Center
-
-
New York
-
New York, New York, United States, 10016
- NYU Langone
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Atrium Health Sanger Heart and Vascular Institute
-
-
Ohio
-
Cincinnati, Ohio, United States, 45219
- The Christ Hospital
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
-
Tennessee
-
Nashville, Tennessee, United States, 37205
- Ascension St. Thomas West
-
-
Texas
-
Plano, Texas, United States, 75093
- Baylor Scott & White, The Heart Hospital
-
-
Utah
-
Murray, Utah, United States, 84107
- Intermountain Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Eighteen (18) years of age or greater
- Moderate to severe (≥3+) or severe (≥4+) mitral valve regurgitation (per American Society of Echocardiography (ASE) guidelines) due to mitral valve prolapse or flail
- Intermediate or high surgical risk for mitral valve repair
Exclusion Criteria:
- History of rheumatic heart disease
- History of prior endocarditis
- History of prior repair or replacement of the mitral valve, or annuloplasty
- Severely calcified mitral leaflet or has evidence of calcification in the grasping area of the leaflets that would prevent leaflet anchor positioning and deployment
- Complex mechanism of MR (leaflet perforation, severe leaflet calcifications, commissural extension, commissural prolapse, multiple flail or prolapsing segments, cleft) present on required imaging
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CardioMech Mitral Valve Repair System (MVRS)
|
CardioMech MVRS |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in MR grade
Time Frame: 30 days
|
30 days
|
|
Freedom from serious adverse events determined to be related to the CardioMech MVRS device or procedure
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mathew Williams, MD, NYU Langone
- Principal Investigator: Mayra Guerrero, MD, Mayo Clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10228
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.